Mayo Clinic
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Mayo Clinic sits in the top decile of US sponsors by registered trial count (#2 of 15,751 sponsors by registered trial count).
Mayo Clinic: 2,844 sponsored US clinical trials, 544 recruiting.
Mayo Clinic sponsors 2,844 registered US clinical trials on ClinicalTrials.gov, 544 of them currently recruiting, and 1,816 completed. 252 of these trials are in Phase 3-4 (later-stage) and 821 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Healthy, with 36 trials.
Top-decile sponsor footprint
Mayo Clinic ranks in the top decile of sponsors by registered trial count (#2 of 15,751 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Open and recent trials
2,844 total, page 23 of 57
Examining Behaviors of Teachers of Invasive Bedside Procedures Using an Eye Tracking Device
NCT04235790
TENS Used for Pain Management During Office Cystoscopy Botox Injections
NCT04448171
Docetaxel With or Without Bintrafusp Alfa for the Treatment of Advanced Non-small Cell Lung Cancer
NCT04396535
Provider Perspectives on Beta-lactam Therapeutic Drug Monitoring Programs in the Critically Ill
NCT04755777
A Multi-Center Clinical Trial to Determine the Impact of a Mobile Health Application on Rheumatoid Arthritis Shared Decision Making
NCT03773471
HPV Educational Intervention to Increase Acceptance and Completion of Free HPV Vaccination Among Underserved Adults
NCT04474821
Non-pharmacological Pain Management After Surgery
NCT04570371
Home Telemonitoring In Patients After Myocardial Infarction
NCT04664881
Operative Curriculum Gallbladder Surgery
NCT04691206
Long-term Monitoring of Patients With Cardiac Amyloidosis With Implantable Event Monitors
NCT04421040
Study of Mucosal Sparing Adjuvant Radiotherapy After Surgical Exploration in HPV+ Head and Neck Cancer of Unknown Primaries
NCT04489212
Platelet-rich Plasma for Thumb Carpometacarpal Joint Osteoarthritis
NCT04886349
Prospective Evaluation of Biliary Tissue Sampling With ERCP
NCT04572711
Effect of 1,25-dihydroxyvitamin D3, Treatment on Insulin Secretion and Muscle Strength in Pre-diabetic Persons
NCT04286529
A Study to Evaluate Endoscope-assisted, Minimally-invasive Cortical Access System for Chronic Subdural Evacuation
NCT04502745
Automated Retinal Image Analysis System (EyeQuant) for Computation of Vascular Biomarkers
NCT04567745
Zinc Versus Multivitamin Micronutrient Supplementation in the Setting of COVID-19
NCT04551339
Predicting Placental Pathologies by Ultrasound Imaging
NCT04506970
Nitrates and IL-8 in Barrett's Esophagus
NCT04642690
Platelet Rich Plasma for the Treatment of Genitourinary Syndrome of Menopause in Patients With Stage 0-III Breast Cancer
NCT04535323
The ICE WATCHMAN Trial
NCT04569734
Acamprosate Safe to Use in Individuals With Liver Disease.
NCT04287920
Primary Care Referrals to Community-based Lifestyle Programs for Management of Obesity
NCT04433806
Rifaximin for the Treatment of Gastrointestinal Toxicities Related to Pertuzumab-Based Therapy in Patients With Stage I-III HER2 Positive Breast Cancer
NCT04249622
Rapid Diagnostic Supporting Antimicrobial Stewardship in Patients With Pneumonia
NCT05937126
Investigate the Mechanisms, Predictors, and Prevention of Persistent Post-Traumatic Headache
NCT04369729
Consent Forms in Cancer Research: Examining the Effect of Length on Readability
NCT04548063
"Prescribing" Exercise to Cancer Patients At High-Risk for Falls
NCT04236154
Molecular Mechanisms of Exercise Benefits to Insulin Resistant People
NCT04158375
A Study to Assess Metabolic Bone Disease of Prematurity Using an Acoustic Method
NCT04752098
Aloud Real-time Reading of ICU Diaries for Prevention of Negative Post-ICU Psychological Outcomes
NCT04510272
Dupilumab for the Treatment of Moderate to Severe Chronic Hepatic Pruritus
NCT04256759
Impact of Predictive Modeling on Time to Palliative Care in an Outpatient Primary Care Population
NCT04604457
RBX7455 Before Surgery for the Treatment of Operable Breast Cancer
NCT04139993
Stories for Change: Digital Storytelling Intervention for Diabetes Self-Management in the COVID-19 Pandemic
NCT04738032
Effect of Medically-tailored Meal Delivery Service on Changes in Hemoglobin A1c (HbA1c) in Patients With Diabetes
NCT04523155
Invasive Hemodynamic Response to Transcatheter Edge-to-Edge Mitral Valve Repair
NCT04200378
Interactive Care Plan for the Monitoring of Symptoms and Recovery in Patients With Stage 0-III Breast Cancer
NCT04693338
Electromyographic and Acceleromyographic Monitoring in Restricted Arm Movement Surgical Setting
NCT04352140
Visual and Electromyography Assessments in Response to Train-of-Four Stimulation of the Ulnar Nerve
NCT04352127
Thumb vs Great Toe Recovery
NCT04312256
A Study to Implement and Evaluate REFLECT Communication Curriculum for Oncology Based Medical Graduate Students
NCT04557696
18F-fluciclovine PET/MRI Imaging for the Detection of Tumor Recurrence After Radiation Injury to the Brain
NCT04462419
Positive Suggestions Via MP3 Messages
NCT04437095
Enhanced Kidney Follow-up for AKI Survivors in Care Transitions
NCT04505891
PET/CT Quantitative Assessment of Myocardial Blood Flow Changes in Oncologic Patients Receiving Checkpoint Inhibitor Therapy
NCT04538950
Post-discharge Early Assessment With a Video-visit
NCT04547803
Pathogenesis and Mechanisms of Mitral Annular Calcification
NCT04286009
8 Week Multi-site Study of MYDAYIS® for Bipolar Depression
NCT04235686
Gastric Emptying Using Two Imaging Methods for Those Who Have Undergone POSE2 Weight Loss Procedure
NCT04502732
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 435 |
| Phase 2 | 386 |
| Phase 3 | 86 |
| Phase 4 | 166 |
Therapeutic Areas
What is open in the Mayo Clinic pipeline
544 recruiting of 2,844 indexed (19% open); 1,816 completed (64%).
Phase mix: 252 late (III/IV) vs 821 early (I/II) (early-phase heavy).
Top condition: Healthy (36 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page aggregates every registered trial from this sponsor, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.